Cargando…
miR‐140‐3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2
Recent studies have identified microRNAs (miRNAs) as a compelling novel class of biomarker in colorectal cancer (CRC) development and metastasis. Here, we demonstrated that the level of plasma exosomal miR‐140‐3p in CRC patients was lower than that in healthy controls. The decreased miR‐140‐3p level...
Autores principales: | Liu, Dingsheng, Chen, Chunsheng, Cui, Mingming, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124101/ https://www.ncbi.nlm.nih.gov/pubmed/33838016 http://dx.doi.org/10.1002/cam4.3840 |
Ejemplares similares
-
MiR-140 promotes the progression of intracranial aneurysms by targeting BCL2L2
por: Deng, Jun, et al.
Publicado: (2022) -
Up‐regulation of miR‐497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl‐2
por: Zhu, Danhua, et al.
Publicado: (2017) -
MiR‐335‐5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
por: Liu, Ruonan, et al.
Publicado: (2018) -
MiR-140-3p Impedes Gastric Cancer Progression and Metastasis by Regulating BCL2/BECN1-Mediated Autophagy
por: Chen, Jianliang, et al.
Publicado: (2021) -
Nonconserved miR‐608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 pathways by targeting the 3′‐UTRs of RAC2/BCL2L1 and the coding region of PAK4
por: Zhang, Xu, et al.
Publicado: (2019)